Paroxetine tablets USP, 30mg, 30-count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534, NDC 68382-099-06, UPC 3 6838209906 8

Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets

Recall #: D-1137-2017
Affected scope: 44800 bottles
Initiated: August 18, 2017

Compiled from official public sources by the publisher. · Updated September 2026

Zydus Pharmaceuticals USA Inc recalled Paroxetine tablets USP, 30mg, 30-count bottles, Rx Only, Manufactured by: Cadila Healthca… - a moderate-severity action.

Paroxetine tablets USP, 30mg, 30-count bottles, Rx Only, Manufactured by: Cadila Healthca… was recalled by Zydus Pharmaceuticals USA Inc in September 20, 2017. Reason: Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets. Check the official notice for the remedy. Verify recall #D-1137-2017 with the FDA Drug before acting.

The recall

Zydus Pharmaceuticals USA Inc issued this moderate-severity FDA Drug recall-Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets.

Moderate
severity level: Class II
classification: September 20, 2017
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-1137-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 1 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Paroxetine tablets USP, 30mg, 30-count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534, NDC 68382-099-06, UPC 3 6838209906 8

Reason for recall

Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Moderate (Class II)
Status	Terminated
Recall number	D-1137-2017
Date reported	September 20, 2017
Date initiated	August 18, 2017
Recalling firm	Zydus Pharmaceuticals USA Inc
Firm location	Pennington, NJ
Affected scope	44800 bottles
Distribution	Nationwide within United States

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-1137-2017) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Why was this product recalled? ▼

Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on September 20, 2017. Severity: Moderate. Recall number: D-1137-2017.

Where was the recalled product distributed? ▼

Distribution: Nationwide within United States.

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Moderate), closest by report date among other firms and states.

John Deere Recalls Lawn Tractors and Serv… 2017-09-20 DEMDACO Recalls Infant Bib and Bootie Set… 2017-09-20 Fireworks Over America Recalls Fireworks … 2017-09-20 Doctor Manzanilla Allergy & Decongestant … 2017-09-20

Similar Children & Baby Products · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Doctor Manzanilla Cough & Cold (diphenhyd… 2017-09-20 Delta Recalls Strollers Due to Fall Hazard 2017-09-25 Famotidine for Oral Suspension USP, 40 mg… 2017-09-13 Povidone Iodine, USP Prep Solution, 10%, … 2017-09-13

Compare this recall with CLEAR EYES Maximum Itchy Eye Relief, 0.5 fl oz (15 mL) per … → · All Children & Baby Products recalls

This recall: FDA Drug, reported September 20, 2017. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026